Canadian Journal of Gastroenterology (Jan 2013)

A Pilot Study Examining the Relationship among Crohn Disease Activity, Glucagon-Like Peptide-2 Signalling and Intestinal Function in Pediatric Patients

  • David L Sigalet,
  • Dragan Kravarusic,
  • Decker Butzner,
  • Bolette Hartmann,
  • Jens J Holst,
  • Jon Meddings

DOI
https://doi.org/10.1155/2013/460958
Journal volume & issue
Vol. 27, no. 10
pp. 587 – 592

Abstract

Read online

BACKGROUND/OBJECTIVES: The relationship between the enteroendocrine hormone glucagon-like peptide 2 (GLP-2) and intestinal inflammation is unclear. GLP-2 promotes mucosal growth, decreases permeability and reduces inflammation in the intestine; physiological stimulation of GLP-2 release is triggered by nutrient contact. The authors hypothesized that ileal Crohn disease (CD) affects GLP-2 release.